within Pharmacolibrary.Drugs.ATC.G;

model G03AD01_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.99,
    Cl             = 8e-06,
    adminDuration  = 600,
    adminMass      = 0.15 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.03333333333333333,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G03AD01_1</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Levonorgestrel is a synthetic progestogen (progestin) used primarily in hormonal contraceptives for women, including emergency contraception (the 'morning after pill') and regular oral contraceptive pills. It is approved and widely used globally for contraception.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult women using daily oral contraceptive dose.</p><h4>References</h4><ol><li><p>Leelakanok, N, &amp; Methaneethorn, J (2020). A Systematic Review and Meta-analysis of the Adverse Effects of Levonorgestrel Emergency Oral Contraceptive. <i>Clinical drug investigation</i> 40(5) 395–420. DOI:<a href=&quot;https://doi.org/10.1007/s40261-020-00901-x&quot;>10.1007/s40261-020-00901-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32162237/&quot;>https://pubmed.ncbi.nlm.nih.gov/32162237</a></p></li><li><p>Ginstman, C, et al., &amp; Brynhildsen, J (2020). Pharmacokinetics of Oral Levonorgestrel in Women After Roux-en-Y Gastric Bypass Surgery and in BMI-Matched Controls. <i>Obesity surgery</i> 30(6) 2217–2224. DOI:<a href=&quot;https://doi.org/10.1007/s11695-020-04447-x&quot;>10.1007/s11695-020-04447-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32030619/&quot;>https://pubmed.ncbi.nlm.nih.gov/32030619</a></p></li><li><p>Moreira de Brito, C, et al., &amp; Cercato, C (2021). Pharmacokinetics of oral levonorgestrel and ethinylestradiol in women after Roux-en-Y gastric bypass surgery. <i>Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery</i> 17(4) 673–681. DOI:<a href=&quot;https://doi.org/10.1016/j.soard.2020.12.007&quot;>10.1016/j.soard.2020.12.007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33547015/&quot;>https://pubmed.ncbi.nlm.nih.gov/33547015</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G03AD01_1;
